Trial Profile
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs S 707106 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Apr 2012 Planned End Date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 13 Sep 2011 Additional location (Puerto Rico) identified as reported by ClinicalTrials.gov.
- 13 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.